We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $15.2B
1-Year Est. Return 55.75%
This Fund
S&P 500
This Quarter Est. Return
+21.65%
1 Year Est. Return
+55.75%
3 Year Est. Return
+134.64%
5 Year Est. Return
+55.21%
10 Year Est. Return
+628.45%
AUM
$15.2B
AUM Growth
+$586M
Cap. Flow
+$1.26B
Cap. Flow %
8.33%
Top 10 Hldgs %
30.61%
Holding
2,149
New
466
Increased
491
Reduced
450
Closed
528

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.01%
2 Healthcare 12.03%
3 Technology 11.01%
4 Consumer Discretionary 5.82%
5 Financials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
1776
Manhattan Associates
MANH
$12B
– –
-2,279
Closed -$303K
MAS icon
1777
Masco
MAS
$13.6B
– –
-8,448
Closed -$510K
MAX icon
1778
MediaAlpha
MAX
$491M
– –
-10,000
Closed -$93K
MAX icon
1779
PUT
MediaAlpha
MAX
$491M
– –
-10,000
Closed -$93K
MCY icon
1780
CALL
Mercury Insurance
MCY
$5.51B
– –
-52,000
Closed -$4.58M
MCY icon
1781
Mercury Insurance
MCY
$5.51B
– –
-3,241
Closed -$286K
MDB icon
1782
MongoDB
MDB
$33.1B
– –
-3,595
Closed -$880K
MGTX icon
1783
MeiraGTx Holdings
MGTX
$1.05B
– –
-167,452
Closed -$1.45M
MHO icon
1784
M/I Homes
MHO
$3.51B
– –
-6,120
Closed -$749K
MKTX icon
1785
MarketAxess Holdings
MKTX
$5.78B
– –
-8,190
Closed -$1.35M
MLI icon
1786
Mueller Industries
MLI
$13.4B
– –
-8,286
Closed -$459K
MLR icon
1787
Miller Industries
MLR
$613M
– –
-6,212
Closed -$283K
MLTX icon
1788
MoonLake Immunotherapeutics
MLTX
$1.02B
– –
-500,000
Closed -$9.32M
MMM icon
1789
CALL
3M
MMM
$87.4B
– –
-3,200
Closed -$465K
MP icon
1790
MP Materials
MP
$8.7B
– –
-5,172
Closed -$250K
MPLX icon
1791
MPLX
MPLX
$57.6B
– –
-12,019
Closed -$686K
MRAM icon
1792
Everspin Technologies
MRAM
$450M
– –
-10,647
Closed -$93.6K
MS icon
1793
PUT
Morgan Stanley
MS
$308B
– –
-10,000
Closed -$1.65M
MSCI icon
1794
CALL
MSCI
MSCI
$40.1B
– –
-2,100
Closed -$1.13M
MSGS icon
1795
Madison Square Garden
MSGS
$9.7B
– –
-1,704
Closed -$548K
MYRG icon
1796
MYR Group
MYRG
$4.56B
– –
-2,427
Closed -$685K
NABL icon
1797
N-able
NABL
$756M
– –
-31,849
Closed -$149K
NBIX icon
1798
CALL
Neurocrine Biosciences
NBIX
$14.1B
– –
-2,500
Closed -$329K
NCLH icon
1799
CALL
Norwegian Cruise Line
NCLH
$6.71B
– –
-300,000
Closed -$5.61M
NDAQ icon
1800
PUT
Nasdaq
NDAQ
$52.3B
– –
-69,100
Closed -$5.87M

Similar funds

Jefferies Financial Group's Q2 2026 Portfolio in Review

As of Q2 2026, Jefferies Financial Group held 2,149 positions worth $15.2B, up 4% from $14.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Jefferies Financial Group deployed $1.26B of net new capital in Q2 2026, opening 466 new positions and adding to 491 existing holdings. Its largest new stake was CG Oncology: 769,947 shares worth $54.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 61% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Broadcom, an estimated $131M trimmed.

  • Jefferies Financial Group's largest Q2 2026 buy was CG Oncology: 769,947 shares worth $54.7M.
  • Jefferies Financial Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $380M increase.
  • Jefferies Financial Group's biggest Q2 2026 reduction was Broadcom, cutting an estimated $131M.
  • Jefferies Financial Group fully exited Ashland in Q2 2026, selling an estimated $106M.
  • Jefferies Financial Group's ten largest holdings make up 31% of its $15.2B portfolio in Q2 2026.
  • Jefferies Financial Group opened 466 new positions and closed 528 in Q2 2026.
  • Jefferies Financial Group's portfolio value rose 4% quarter-over-quarter to $15.2B.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.